PDE6B and tuberculosis: Compared to those who had not previously received TB treatment, treated patients had a 5.6-fold lower proportion of positive ELISPOT responses to RD1 antigens (P < 0.01) and a 2.4-fold lower proportion of positive ELISPOT responses to PPD (P = 0.02) (Figure 1).